Strata Financial Statements From 2010 to 2026

SRTA Stock   4.82  0.10  2.12%   
Strata Critical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Strata Critical's valuation are provided below:
Gross Profit
13.2 M
Profit Margin
(0.55)
Market Capitalization
417.3 M
Enterprise Value Revenue
1.0716
Revenue
67.2 M
We have found one hundred twenty available fundamental trend indicators for Strata Critical Medical, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Strata Critical Medical current market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. As of February 4, 2026, Market Cap is expected to decline to about 236.1 M. In addition to that, Enterprise Value is expected to decline to about 229.7 M

Strata Critical Total Revenue

300.3 Million

Check Strata Critical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Strata Critical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.2 M, Selling General Administrative of 53 M or Selling And Marketing Expenses of 6.7 M, as well as many indicators such as Price To Sales Ratio of 1.45, Dividend Yield of 0.0 or PTB Ratio of 1.62. Strata financial statements analysis is a perfect complement when working with Strata Critical Valuation or Volatility modules.
  
Build AI portfolio with Strata Stock
Check out the analysis of Strata Critical Correlation against competitors.

Strata Critical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets276.5 M295.2 M269.3 M
Very volatile
Short and Long Term Debt Total10.1 M10.7 M4.7 M
Slightly volatile
Total Current Liabilities19.1 M26.1 MM
Slightly volatile
Total Stockholder Equity190.3 M255.2 M89.9 M
Slightly volatile
Cash19 M21.1 M9.1 M
Slightly volatile
Non Current Assets Total81.6 M86.3 M192.1 M
Slightly volatile
Cash And Short Term Investments140.9 M114.4 M224.1 M
Slightly volatile
Common Stock Shares Outstanding57.2 M89.1 M30.9 M
Slightly volatile
Short Term Investments152.5 M97.9 M233.5 M
Slightly volatile
Liabilities And Stockholders Equity276.5 M295.2 M269.3 M
Very volatile
Non Current Liabilities Total17.1 M13.8 M7.4 M
Slightly volatile
Other Stockholder Equity292.3 M468.1 M140.7 M
Slightly volatile
Total Liabilities29.7 M31.3 M175.6 M
Slightly volatile
Total Current Assets164.2 M184.9 M74 M
Slightly volatile
Short Term Debt2.5 M3.8 M1.3 M
Slightly volatile
Common Stock5.7 K8.1 K2.7 K
Slightly volatile
Property Plant And Equipment Net48.1 M45.8 M12.3 M
Slightly volatile
Current Deferred Revenue6.6 M7.7 MM
Slightly volatile
Accounts Payable20 M19 M6.1 M
Slightly volatile
Non Currrent Assets Other998.1 K1.7 M485.7 K
Slightly volatile
Net Receivables13.2 M24.8 M6.4 M
Slightly volatile
Inventory801.5 K1.3 M685.7 K
Slightly volatile
Intangible Assets23.2 M15.7 M8.8 M
Slightly volatile
Good Will36.9 M47.2 M21.5 M
Slightly volatile
Capital Lease Obligations14.5 M10.7 M5.1 M
Slightly volatile
Net Invested Capital204.4 M199.7 M272.4 M
Slightly volatile
Long Term Investments324.5 K448.5 K255.5 K
Slightly volatile
Property Plant And Equipment Gross27.8 M51.9 M13.4 M
Slightly volatile
Capital Stock5.6 K6.3 K6.9 K
Slightly volatile
Net Working Capital156.5 M124.2 M245.1 M
Slightly volatile

Strata Critical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative53 M94 M31.2 M
Slightly volatile
Selling And Marketing Expenses6.7 M9.1 M5.7 M
Slightly volatile
Total Revenue300.3 M286 M93.7 M
Slightly volatile
Gross Profit71.1 M67.8 M18.9 M
Slightly volatile
Other Operating Expenses169.9 M325 M106.3 M
Slightly volatile
Research Development3.1 M3.7 M1.8 M
Slightly volatile
Cost Of Revenue229.2 M218.2 M74.7 M
Slightly volatile
Total Operating Expenses62.8 M106.8 M38.7 M
Slightly volatile
Interest Expense800900982
Slightly volatile
Net Interest Income5.4 M8.3 M2.3 M
Slightly volatile
Interest Income5.4 M8.3 M2.3 M
Slightly volatile
Reconciled Depreciation5.3 M6.9 M2.2 M
Slightly volatile

Strata Critical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation24 M22.9 M5.9 M
Slightly volatile
Begin Period Cash Flow27.3 M33.4 M30.1 M
Slightly volatile
Depreciation3.7 M6.9 M2.1 M
Slightly volatile
Capital Expenditures39.8 M37.9 M7.3 M
Slightly volatile
End Period Cash Flow24.8 M22.6 M22.5 M
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.451.524.3518
Slightly volatile
PTB Ratio1.621.717.4643
Slightly volatile
Days Sales Outstanding24.028.5222.5154
Slightly volatile
Book Value Per Share2.082.581.8366
Slightly volatile
Stock Based Compensation To Revenue0.05510.0720.045
Slightly volatile
Capex To Depreciation5.234.981.5235
Slightly volatile
PB Ratio1.621.717.4643
Slightly volatile
EV To Sales1.411.484.0896
Slightly volatile
Inventory Turnover45.7465.8352.3247
Slightly volatile
Days Of Inventory On Hand7.615.747.4612
Slightly volatile
Payables Turnover15.038.6119.5222
Slightly volatile
Sales General And Administrative To Revenue0.460.380.4087
Pretty Stable
Research And Ddevelopement To Revenue0.0140.01470.0309
Slightly volatile
Capex To Revenue0.130.120.0347
Slightly volatile
Cash Per Share1.791.893.7331
Pretty Stable
Days Payables Outstanding32.0743.8627.2453
Slightly volatile
Income Quality0.10.110.8545
Slightly volatile
Intangibles To Total Assets0.140.190.0995
Slightly volatile
Net Debt To EBITDA0.350.370.6658
Slightly volatile
Current Ratio6.76.375.2751
Slightly volatile
Tangible Book Value Per Share1.641.941.4869
Slightly volatile
Receivables Turnover14.5813.2517.6847
Slightly volatile
Shareholders Equity Per Share2.082.581.8366
Slightly volatile
Debt To Equity0.08780.04830.1202
Slightly volatile
Capex Per Share0.40.380.0973
Slightly volatile
Graham Net Net1.31.261.0985
Slightly volatile
Revenue Per Share2.783.692.2741
Slightly volatile
Interest Debt Per Share0.130.110.1552
Pretty Stable
Debt To Assets0.03820.03270.0744
Slightly volatile
Operating Cycle26.2228.5228.1477
Slightly volatile
Price Book Value Ratio1.621.717.4643
Slightly volatile
Days Of Payables Outstanding32.0743.8627.2453
Slightly volatile
Ebt Per Ebit1.090.930.9591
Pretty Stable
Effective Tax Rate0.01010.01060.0604
Slightly volatile
Company Equity Multiplier1.261.334.6149
Very volatile
Long Term Debt To Capitalization0.03540.03980.0434
Slightly volatile
Total Debt To Capitalization0.07890.04640.1048
Slightly volatile
Debt Equity Ratio0.08780.04830.1202
Slightly volatile
Quick Ratio6.696.375.2292
Slightly volatile
Net Income Per E B T0.770.890.9208
Very volatile
Cash Ratio1.610.931.6597
Slightly volatile
Days Of Inventory Outstanding7.615.747.4612
Slightly volatile
Days Of Sales Outstanding24.028.5222.5154
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio13.3212.693.2153
Slightly volatile
Price To Book Ratio1.621.717.4643
Slightly volatile
Fixed Asset Turnover10.987.199.4102
Pretty Stable
Debt Ratio0.03820.03270.0744
Slightly volatile
Price Sales Ratio1.451.524.3518
Slightly volatile
Asset Turnover0.50.870.9512
Slightly volatile
Gross Profit Margin0.140.210.1371
Slightly volatile
Price Fair Value1.621.717.4643
Slightly volatile

Strata Critical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap236.1 M296.4 M209.7 M
Slightly volatile
Enterprise Value229.7 M288.3 M199.8 M
Slightly volatile

Strata Fundamental Market Drivers

About Strata Critical Financial Statements

Strata Critical stakeholders use historical fundamental indicators, such as Strata Critical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Strata Critical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Strata Critical's assets and liabilities are reflected in the revenues and expenses on Strata Critical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Strata Critical Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue7.7 M6.6 M
Total Revenue286 M300.3 M
Cost Of Revenue218.2 M229.2 M
Stock Based Compensation To Revenue 0.07  0.06 
Sales General And Administrative To Revenue 0.38  0.46 
Research And Ddevelopement To Revenue 0.01  0.01 
Capex To Revenue 0.12  0.13 
Revenue Per Share 3.69  2.78 
Ebit Per Revenue(0.12)(0.13)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Strata Critical Medical is a strong investment it is important to analyze Strata Critical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Strata Critical's future performance. For an informed investment choice regarding Strata Stock, refer to the following important reports:
Check out the analysis of Strata Critical Correlation against competitors.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Ground Transportation space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Strata Critical. If investors know Strata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Strata Critical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.24)
Revenue Per Share
1.244
Quarterly Revenue Growth
2.083
Return On Assets
(0.11)
Return On Equity
(0.24)
The market value of Strata Critical Medical is measured differently than its book value, which is the value of Strata that is recorded on the company's balance sheet. Investors also form their own opinion of Strata Critical's value that differs from its market value or its book value, called intrinsic value, which is Strata Critical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Strata Critical's market value can be influenced by many factors that don't directly affect Strata Critical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Strata Critical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Strata Critical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Strata Critical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.